BACKGROUND AIMS: Delivery of bone marrow-derived stem and progenitor cells to the site of injury is an effective strategy to enhance bone healing. An alternate approach is to mobilize endogenous, heterogeneous stem cells that will home to the site of injury. AMD3100 is an antagonist of the chemokine receptor 4 (CXCR4) that rapidly mobilizes stem cell populations into peripheral blood. Our hypothesis was that increasing circulating numbers of stem and progenitor cells using AMD3100 will improve bone fracture healing. METHODS: A transverse femoral fracture was induced in C57BL/6 mice, after which they were subcutaneously injected for 3 d with AMD3100 or saline control. Mesenchymal stromal cells, hematopoietic stem and progenitor cells and endothelial progenitor cells in the peripheral blood and bone marrow were evaluated by means of flow cytometry, automated hematology analysis and cell culture 24 h after injection and/or fracture. Healing was assessed up to 84 d after fracture by histomorphometry and micro-computed tomography. RESULTS: AMD3100 injection resulted in higher numbers of circulating mesenchymal stromal cells, hematopoietic stem cells and endothelial progenitor cells. Micro-computed tomography data demonstrated that the fracture callus was significantly larger compared with the saline controls at day 21 and significantly smaller (remodeled) at day 84. AMD3100-treated mice have a significantly higher bone mineral density than do saline-treated counterparts at day 84. CONCLUSIONS: Our data demonstrate that early cell mobilization had significant positive effects on healing throughout the regenerative process. Rapid mobilization of endogenous stem cells could provide an effective alternative strategy to cell transplantation for enhancing tissue regeneration.
BACKGROUND AIMS: Delivery of bone marrow-derived stem and progenitor cells to the site of injury is an effective strategy to enhance bone healing. An alternate approach is to mobilize endogenous, heterogeneous stem cells that will home to the site of injury. AMD3100 is an antagonist of the chemokine receptor 4 (CXCR4) that rapidly mobilizes stem cell populations into peripheral blood. Our hypothesis was that increasing circulating numbers of stem and progenitor cells using AMD3100 will improve bone fracture healing. METHODS: A transverse femoral fracture was induced in C57BL/6 mice, after which they were subcutaneously injected for 3 d with AMD3100 or saline control. Mesenchymal stromal cells, hematopoietic stem and progenitor cells and endothelial progenitor cells in the peripheral blood and bone marrow were evaluated by means of flow cytometry, automated hematology analysis and cell culture 24 h after injection and/or fracture. Healing was assessed up to 84 d after fracture by histomorphometry and micro-computed tomography. RESULTS:AMD3100 injection resulted in higher numbers of circulating mesenchymal stromal cells, hematopoietic stem cells and endothelial progenitor cells. Micro-computed tomography data demonstrated that the fracture callus was significantly larger compared with the saline controls at day 21 and significantly smaller (remodeled) at day 84. AMD3100-treated mice have a significantly higher bone mineral density than do saline-treated counterparts at day 84. CONCLUSIONS: Our data demonstrate that early cell mobilization had significant positive effects on healing throughout the regenerative process. Rapid mobilization of endogenous stem cells could provide an effective alternative strategy to cell transplantation for enhancing tissue regeneration.
Authors: Chrisoula A Toupadakis; Alice Wong; Damian C Genetos; Dai-Jung Chung; Deepa Murugesh; Matthew J Anderson; Gabriela G Loots; Blaine A Christiansen; Amy S Kapatkin; Clare E Yellowley Journal: J Orthop Res Date: 2012-05-16 Impact factor: 3.494
Authors: Margaret A McNulty; Amarjit S Virdi; Kent W Christopherson; Kotaro Sena; Robin R Frank; Dale R Sumner Journal: Clin Orthop Relat Res Date: 2012-09 Impact factor: 4.176
Authors: W Conrad Liles; Hal E Broxmeyer; Elin Rodger; Brent Wood; Kai Hübel; Scott Cooper; Giao Hangoc; Gary J Bridger; Geoffrey W Henson; Gary Calandra; David C Dale Journal: Blood Date: 2003-07-10 Impact factor: 22.113
Authors: Anusuya Das; Claire E Segar; Yihsuan Chu; Tiffany W Wang; Yong Lin; Chunxi Yang; Xeujun Du; Roy C Ogle; Quanjun Cui; Edward A Botchwey Journal: Biomaterials Date: 2015-06-14 Impact factor: 12.479
Authors: Jada M Selma; Anusuya Das; Anthony O Awojoodu; Tiffany Wang; Anjan P Kaushik; Quanjun Cui; Hannah Song; Molly E Ogle; Claire E Olingy; Emily G Pendleton; Kayvan F Tehrani; Luke J Mortensen; Edward A Botchwey Journal: Cell Mol Bioeng Date: 2018-05-29 Impact factor: 2.321
Authors: Luigi Mele; Pietro Paolo Vitiello; Virginia Tirino; Francesca Paino; Alfredo De Rosa; Davide Liccardo; Gianpaolo Papaccio; Vincenzo Desiderio Journal: Front Physiol Date: 2016-02-24 Impact factor: 4.566